Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gilead Sciences
Gilead Sciences
ASH: Bristol Myers' Breyanzi, Gilead's Yescarta lock horns in race to move CAR-T therapy to earlier lymphoma
Fierce Pharma
Sat, 12/11/21 - 09:22 pm
Gilead Sciences
Yescarta
Bristol Myers Squibb
Breyanzi
CAR-T
lymphoma
Digital pill tracks HIV PrEP adherence with 98% accuracy
Pharmaforum
Thu, 12/9/21 - 10:38 am
digital pills
HIV
PrEP
Gilead Sciences
AZ, Daiichi take aim at Gilead in triple-negative breast cancer
Pharmaforum
Wed, 12/8/21 - 10:37 am
AstraZeneca
Daiichi Sankyo
Gilead Sciences
Trodelvy
triple negative breast cancer
Dato-DXd
Gilead recalls 2 lots of COVID-19 drug Veklury after finding glass particulates in vials
Fierce Pharma
Mon, 12/6/21 - 10:38 am
Gilead Sciences
product recalls
Veklury
COVID-19
drug manufacturing
Mei, with Bayer and Gilead in its sights, posts pivotal data on blood cancer prospect
Fierce Biotech
Tue, 11/30/21 - 10:41 am
MEI Pharma
blood cancer
follicular lymphoma
zandelisib
Bayer
Gilead Sciences
Gilead files first hepatitis delta therapy with FDA
Pharmaforum
Mon, 11/22/21 - 10:25 am
Gilead Sciences
buleviritide
antivirals
hepatitis delta
FDA
Why Arcus Biosciences Stock Is On Fire Today
Motley Fool
Thu, 11/18/21 - 10:41 am
Arcus Biosciences
Gilead Sciences
anti-TIGIT
etrumadenant
quemliclustat
Despite strong quarter, some wonder how long Gilead can rely on coronavirus drug
BioPharma Dive
Fri, 10/29/21 - 11:17 am
Gilead Sciences
earnings
Veklury
remdesivir
COVID-19
Gilead Sciences : Study Data Of Biktarvy In People Living With HIV Show High Effectiveness
NASDAQ
Fri, 10/29/21 - 11:05 am
Gilead Sciences
Biktarvy
HIV
RWE
Gilead, Merck to study combination therapy for breast cancer
Pharmaceutical Business Review
Fri, 10/29/21 - 10:56 am
Gilead Sciences
Merck
Trodelvy
Keytruda
triple negative breast cancer
Gilead taps brakes on $4.9B bet after rival's failure, pushing blood cancer data out to 2022
Fierce Biotech
Fri, 10/29/21 - 10:35 am
Gilead Sciences
Forty Seven
magrolimab
MDS
Can Merck's Antiviral for COVID Succeed Where Gilead's Failed?
Motley Fool
Sun, 10/24/21 - 10:32 pm
Merck
antivirals
COVID-19
Gilead Sciences
Kite gets US FDA approval for Tecartus to treat acute lymphoblastic leukemia
Pharmaceutical Business Review
Mon, 10/4/21 - 10:39 am
Kite Pharma
Gilead Sciences
Tecartus
FDA
ALL
acute lymphoblastic leukemia
Gilead, Bristol Myers face lawsuit from major pharmacies over HIV generic drug delays
Endpoints
Wed, 09/29/21 - 11:01 am
Gilead Sciences
Teva Pharmaceutical
Bristol Myers Squibb
CVS
Rite Aid
generics
HIV
Oncology the focus for big pharma catalysts
EP Vantage
Tue, 09/28/21 - 11:19 am
Big Pharma
cancer
oncology
Merck
Keytruda
AbbVie
Vraylar
Gilead Sciences
Trodelvy
Sanofi
Sarclisa
Novartis
ligelizumab
Remdesivir reduces Covid hospitalizations when given early, study shows
Stat
Wed, 09/22/21 - 11:20 am
Gilead Sciences
remdesivir
COVID-19
Gilead keeps pushing trove of Trodelvy data as it seeks to become new standard of care in TNBC
Endpoints
Thu, 09/16/21 - 10:42 am
ESMO
Gilead Sciences
Trodelvy
triple negative breast cancer
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
ESMO
oncology
cancer
Gilead Sciences
Bristol Myers Squibb
Zymeworks
Amgen
Adaptimmune Therapeutics
TCR2 Therapeutics
Boehringer Ingelheim
Could Moderna Take Down Gilead Sciences?
Motley Fool
Mon, 08/30/21 - 10:52 am
Moderna Therapeutics
HIV
vaccines
MRNA
Gilead Sciences
Gilead wins reversal of $1.2B fine in CAR-T patent fight with Bristol Myers
Fierce Pharma
Thu, 08/26/21 - 08:52 pm
Gilead Sciences
Kite Pharma
CAR-T
patents
Bristol Myers Squibb
Pages
« first
‹ previous
…
6
7
8
9
10
11
12
13
14
…
next ›
last »